Colorectal cancer (CRC) is the third most common cancer diagnosed in both men and women in the United States. Although the incidence and mortality rate of this disease continues to increase, new evidence in the use of surgical prophylaxis, hereditary risk counseling and modifying lifestyle risk factors is enabling improvements in innovative and progressive therapy options for patients with CRC. Additionally, advances in surgical techniques and screening of high-risk patients reinforce the importance of a multidisciplinary approach to treatment, necessitating ongoing education for health care providers in order to ensure optimal patient care.
At the conclusion of this symposium, the participant will provide better patient care through an increased ability to:
- Demonstrate knowledge of the evidence-based rationale for the use of definitive chemoradiation in localized anal cancer; examine the novel strategies to optimize treatment outcomes and reduce treatment-related mortality; and discuss ongoing and future investigations aimed at individualizing therapy for anal cancer
- Illustrate the technical aspects of Transanal Total Mesorectal Excision (taTME) for rectal cancer; explore the indications and contra-indications to the use of taTME; and discuss the role of taTME in the armamentarium of rectal cancer treatments
- Review inherited colon cancer syndromes; discuss indications for genetic testing for colon cancer and examine genetic testing options related to colon cancer
- Describe the surgical management of Lynch syndrome and familial adenomatous polyposis (FAP)
- Translate the recent data from the international collaboration of six trials comparing 3 vs 6 months of adjuvant chemotherapy for stage III colon cancer and determine which patients are appropriate for 3 months of chemotherapy
- Discuss the importance of the site of primary colon cancer and examine the factors that should be incorporated into decision-making for colon cancer treatment
- Describe the role of physical activity in colorectal cancer survivors; discuss the differences between body mass index and body composition and associations with both on outcomes in colorectal cancer survivors; and evaluate the data of diet and outcomes in colorectal cancer survivors
Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Swedish Medical Center designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours
6.25 nursing contact hours will be provided by Swedish Medical Center Clinical Education and Practice / PA-57 is an approved provider of continuing nursing education by the Washington State Nurses Association Continuing Nursing Education Approver (A-CNE), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Cathleen M. Goetsch, ARNP, AOCNP, AGN-BC
Hereditary Cancer Risk Specialist
Virginia Mason Medical Center Cancer Institute
John Griffin, M.D., FACS, FASCRS
Swedish Colon and Rectal Institute
Swedish Cancer Institute
Lisa A. Kachnic, M.D.
Professor & Chair, Radiation Oncology
Vanderbilt University Medical Center
Jeffrey Meyerhardt, M.D., MPH
Clinical Director; Associate Professor of Medicine
Dana-Farber Cancer Institute
V. Liana Tsikitis, M.D., MCR, FACS, FASCRS
Department of Surgery
Division of General and Gastrointestinal Surgery
Oregon Health & Science University
Alan P. Venook, M.D.
The Madden Family Distinguished Professor of Medical Oncology and Translational Research
University of California San Francisco
San Francisco, CA
Swedish CME maintains full control of the context of every course we provide. It is our policy to identify and resolve all speaker and planner conflicts of interest. Each speaker is required to give a balanced, evidence-based presentation that is free of commercial bias.
Philip J. Gold, M.D., Course Chair
Amir Bastawrous, M.D.
Janice Gibson, RN
Sharlene Gill, M.D.
Hagen Kennecke, M.D.
Drew Schembre, M.D., PASGE, FACG
Somasundaram Subramaniam, M.D., MS
Caye Boosalis, MEd, CME Manager
Michelle Low, CME Specialist
|| Advance Registration
|Allied Health Professional
||Email firstname.lastname@example.org to register
*After October 16, add $30 to Advance Registration Pricing
Pre-registration is required as space is limited. Participants who register by the “Advance Registration” deadline will receive a confirmation postcard after Tuesday, October 17, 2017. Registrations will only be processed when accompanied by full payment.
To receive a refund, notice of cancellation must be received no later than Friday, October 20, 2017.
If you require special accommodations, please contact the CME office at email@example.com or 206-386-2755.
The fee for this course includes catering, all instruction materials, online syllabus access and a certificate of AMA PRA Category 1 Credits™.